Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia. Authors' reply (original) (raw)

Leukemia Research, 2009

Abstract

1. Leuk Res. 2009 Apr;33(4):565-6. Epub 2008 Jun 20. Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia. El Kinge AR, Hatoum HA, Mahfouz RA, Otrock ZK, Jabbour E, Kantarjian H ...

Abdul Rahman Agha El Kinge hasn't uploaded this paper.

Let Abdul Rahman Agha know you want this paper to be uploaded.

Ask for this paper to be uploaded.